Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

MLA

Bill & Melinda Gates Foundation, et al. Bacillus Calmette-Guérin Vaccination for Protection against Recurrent Herpes Labialis: A Nested Randomised Controlled Trial. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1431964632&authtype=sso&custid=ns315887.

APA

Bill & Melinda Gates Foundation, Minderoo Foundation, Royal Children’s Hospital Foundation, Health Services Union New South Wales Branch, Peter Sowerby Foundation, SA Health, Insurance Advisernet Foundation, NAB Foundation, Calvert-Jones Foundation, Modara Pines Charitable Foundation, United Health Foundation, Epworth HealthCare, National Health and Medical Research Council (Australia), Swiss National Science Foundation, Pittet, L. F., Moore, C. L., McDonald, E., Barry, S., Bonten, M., … BRACE Trial Consortium Group. (2023). Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial.

Chicago

Bill & Melinda Gates Foundation, Minderoo Foundation, Royal Children’s Hospital Foundation, Health Services Union New South Wales Branch, Peter Sowerby Foundation, SA Health, Insurance Advisernet Foundation, et al. 2023. “Bacillus Calmette-Guérin Vaccination for Protection against Recurrent Herpes Labialis: A Nested Randomised Controlled Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1431964632&authtype=sso&custid=ns315887.